Novobiocin information

Novobiocin
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	intravenous
ATCvet code	QJ01XX95 (WHO) ;
Pharmacokinetic data
Bioavailability	negligible oral bioavailability
Metabolism	excreted unchanged
Elimination half-life	6 hours
Excretion	renal
Identifiers
	IUPAC name 4-Hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)benzamido]-8-methylcoumarin-7-yl 3-O-carbamoyl-5,5-di-C-methyl-α-L-lyxofuranoside;
CAS Number	303-81-1 ;
PubChem CID	9346;
DrugBank	DB01051 ;
ChemSpider	10226117 ;
UNII	17EC19951N;
KEGG	C05080 ;
ChEMBL	ChEMBL36506 ;
CompTox Dashboard (EPA)	DTXSID3041083 ;
ECHA InfoCard	100.005.589
Chemical and physical data
Formula	C31H36N2O11
Molar mass	612.632 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	152 to 156 °C (306 to 313 °F) (dec.)
	SMILES CC(C)=CCc1c(O)ccc(c1)C(=O)NC=2C(=O)Oc3c(C2O)ccc(c3C)O[C@@H]4OC(C)(C)[C@H](OC)[C@H]([C@H]4O)OC(=O)N;
	InChI InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 ; Key:YJQPYGGHQPGBLI-KGSXXDOSSA-N ;
	(verify)

Novobiocin, also known as albamycin, is an aminocoumarin antibiotic that is produced by the actinomycete Streptomyces niveus, which has recently been identified as a subjective synonym for S. spheroides^[1] a member of the class Actinomycetia. Other aminocoumarin antibiotics include clorobiocin and coumermycin A1.^[2] Novobiocin was first reported in the mid-1950s (then called streptonivicin).^[3]^[4]

^ Lanoot B, Vancanneyt M, Cleenwerck I, Wang L, Li W, Liu Z, Swings J (May 2002). "The search for synonyms among streptomycetes by using SDS-PAGE of whole-cell proteins. Emendation of the species Streptomyces aurantiacus, Streptomyces cacaoi subsp. cacaoi, Streptomyces caeruleus and Streptomyces violaceus". International Journal of Systematic and Evolutionary Microbiology. 52 (Pt 3): 823–9. doi:10.1099/00207713-52-3-823. PMID 12054245.
^ da Silva Eustáquio A (2004). Biosynthesis of aminocoumarin antibiotics in Streptomyces: Generation of structural analogues by genetic engineering and insights into the regulation of antibiotic production (Ph.D. thesis). Universität Tübingen.
^ Hoeksema H, Johnson JL, Hinman JW (December 1955). "Structural studies on streptonivicin, a new antibiotic". Journal of the American Chemical Society. 77 (24): 6710–6711. doi:10.1021/ja01629a129.
^ Smith CG, Dietz A, Sokolski WT, Savage GM (February 1956). "Streptonivicin, a new antibiotic. I. Discovery and biologic studies". Antibiotics & Chemotherapy. 6 (2): 135–142. PMID 24543916.

[1] Lanoot B, Vancanneyt M, Cleenwerck I, Wang L, Li W, Liu Z, Swings J (May 2002). "The search for synonyms among streptomycetes by using SDS-PAGE of whole-cell proteins. Emendation of the species Streptomyces aurantiacus, Streptomyces cacaoi subsp. cacaoi, Streptomyces caeruleus and Streptomyces violaceus". International Journal of Systematic and Evolutionary Microbiology. 52 (Pt 3): 823–9. doi:10.1099/00207713-52-3-823. PMID 12054245.

[E-2] Silva Eustáquio A (2004). Biosynthesis of aminocoumarin antibiotics in Streptomyces: Generation of structural analogues by genetic engineering and insights into the regulation of antibiotic production (Ph.D. thesis). Universität Tübingen.

[3] Hoeksema H, Johnson JL, Hinman JW (December 1955). "Structural studies on streptonivicin, a new antibiotic". Journal of the American Chemical Society. 77 (24): 6710–6711. doi:10.1021/ja01629a129.

[4] Smith CG, Dietz A, Sokolski WT, Savage GM (February 1956). "Streptonivicin, a new antibiotic. I. Discovery and biologic studies". Antibiotics & Chemotherapy. 6 (2): 135–142. PMID 24543916.

Novobiocin information

and 28 Related for: Novobiocin information

Novobiocin

Staphylococcus hominis

Staphylococcus saprophyticus

DNA gyrase

Bacteriostatic agent

Staphylococcus haemolyticus

Chemotherapy

Zosurabalpin

Staphylococcus

Staphylococcus epidermidis

Staphylococcus kloosii

Oxidase test

Topoisomerase inhibitor

McFarland standards

Aminocoumarin

Agar plate

Staphylococcus xylosus

Disk diffusion test

Bacteriology

Coagulase

Type II topoisomerase

Minimum inhibitory concentration

Gram stain

Biosafety cabinet

Lancefield grouping

Growth medium

Antibiotic sensitivity testing

Medical microbiology

Clinical data


AHFS/Drugs.com	International Drug Names
Routes of administration	intravenous
ATCvet code	QJ01XX95 (WHO)
Pharmacokinetic data
Bioavailability	negligible oral bioavailability
Metabolism	excreted unchanged
Elimination half-life	6 hours
Excretion	renal
Identifiers
IUPAC name 4-Hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)benzamido]-8-methylcoumarin-7-yl 3-O-carbamoyl-5,5-di-C-methyl-α-L-lyxofuranoside
CAS Number	303-81-1^Y
PubChem CID	9346
DrugBank	DB01051^Y
ChemSpider	10226117^Y
UNII	17EC19951N
KEGG	C05080^Y
ChEMBL	ChEMBL36506^Y
CompTox Dashboard (EPA)	DTXSID3041083
ECHA InfoCard	100.005.589
Chemical and physical data
Formula	C₃₁H₃₆N₂O₁₁
Molar mass	612.632 g·mol⁻¹
3D model (JSmol)	Interactive image
Melting point	152 to 156 °C (306 to 313 °F) (dec.)
SMILES CC(C)=CCc1c(O)ccc(c1)C(=O)NC=2C(=O)Oc3c(C2O)ccc(c3C)O[C@@H]4OC(C)(C)[C@H](OC)[C@H]([C@H]4O)OC(=O)N
InChI InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1^Y Key:YJQPYGGHQPGBLI-KGSXXDOSSA-N^Y
(verify)